Peter Winstanley

4.9k total citations · 1 hit paper
54 papers, 3.2k citations indexed

About

Peter Winstanley is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Peter Winstanley has authored 54 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Public Health, Environmental and Occupational Health, 12 papers in Epidemiology and 11 papers in Pharmacology. Recurrent topics in Peter Winstanley's work include Malaria Research and Control (36 papers), Mosquito-borne diseases and control (17 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Peter Winstanley is often cited by papers focused on Malaria Research and Control (36 papers), Mosquito-borne diseases and control (17 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Peter Winstanley collaborates with scholars based in United Kingdom, Kenya and United States. Peter Winstanley's co-authors include Stephen A. Ward, Robert W. Snow, William M. Watkins, Kevin Marsh, Geoffrey Pasvol, Catherine Waruiru, Alexis Nzila, Charles R. Newton, Norbert Peshu and E.K. Mberu and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Peter Winstanley

52 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indicators of Life-Threatening Malaria in African Children

1995 798 citations Kevin Marsh, Vicki Marsh et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Winstanley United Kingdom	26	2.6k	482	463	459	426	54	3.2k
C. Luxemburger Thailand	26	3.2k 1.2×	653 1.4×	353 0.8×	660 1.4×	495 1.2×	32	3.6k
S. Looareesuwan Thailand	29	2.7k 1.0×	595 1.2×	303 0.7×	544 1.2×	365 0.9×	36	3.7k
Michael Alifrangis Denmark	37	3.1k 1.2×	394 0.8×	602 1.3×	492 1.1×	668 1.6×	156	3.9k
Theonest K. Mutabingwa Tanzania	34	2.9k 1.1×	416 0.9×	307 0.7×	423 0.9×	482 1.1×	55	3.7k
Juntra Karbwang Thailand	38	3.0k 1.2×	973 2.0×	424 0.9×	480 1.0×	371 0.9×	165	4.7k
Srivicha Krudsood Thailand	29	2.3k 0.9×	332 0.7×	349 0.8×	289 0.6×	563 1.3×	118	3.1k
Stephan Duparc Switzerland	28	2.1k 0.8×	526 1.1×	350 0.8×	631 1.4×	289 0.7×	84	2.9k
Aung Pyae Phyo Thailand	29	2.9k 1.1×	426 0.9×	346 0.7×	905 2.0×	517 1.2×	63	3.4k
S Looareesuwan Thailand	32	2.6k 1.0×	540 1.1×	311 0.7×	433 0.9×	628 1.5×	73	3.3k
William M. Watkins United Kingdom	27	2.1k 0.8×	425 0.9×	642 1.4×	440 1.0×	282 0.7×	46	2.8k

Countries citing papers authored by Peter Winstanley

Since Specialization

Citations

This map shows the geographic impact of Peter Winstanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Winstanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Winstanley more than expected).

Fields of papers citing papers by Peter Winstanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Winstanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Winstanley. The network helps show where Peter Winstanley may publish in the future.

Co-authorship network of co-authors of Peter Winstanley

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Winstanley. A scholar is included among the top collaborators of Peter Winstanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Winstanley. Peter Winstanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Albertoni, Riccardo, David J. Browning, Simón Cox, et al.. (2023). The W3C Data Catalog Vocabulary, Version 2: Rationale, Design Principles, and Uptake. Data Intelligence. 6(2). 457–487. 5 indexed citations

2.

Warrell, David A., William M. Watkins, & Peter Winstanley. (2017). Treatment and prevention of malaria. 268–312. 2 indexed citations

3.

Bell, David, Dan Wootton, Mavuto Mukaka, et al.. (2009). Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malaria Journal. 8(1). 204–204. 56 indexed citations

4.

Sisay-Joof, Fatoumatta, Archibald Worwui, Paul Milligan, et al.. (2009). Effects of Genetic Variation at the CYP2C19 / CYP2C9 Locus on Pharmacokinetics of Chlorcycloguanil in Adult Gambians. Pharmacogenomics. 10(9). 1423–1431. 12 indexed citations

5.

Miller, Ann K., Nibedita Bandyopadhyay, Dan Wootton, et al.. (2009). Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria. European Journal of Clinical Pharmacology. 65(10). 977–987. 9 indexed citations

6.

Tiono, Alfred B., Alassane Dicko, D A Ndububa, et al.. (2009). Chlorproguanil–Dapsone–Artesunate versus Chlorproguanil–Dapsone: A Randomized, Double-Blind, Phase III Trial in African Children, Adolescents, and Adults with Uncomplicated Plasmodium falciparum Malaria. American Journal of Tropical Medicine and Hygiene. 81(6). 969–978. 22 indexed citations

7.

Simpson, J. A., Dyfrig Hughes, Christine Manyando, et al.. (2006). Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. British Journal of Clinical Pharmacology. 61(3). 289–300. 20 indexed citations

8.

Nzila, Alexis, Edwin Ochong, Eunice Nduati, et al.. (2005). Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(5). 341–346. 35 indexed citations

9.

Amin, Abdinasir A, Dyfrig Hughes, Vicki Marsh, et al.. (2004). The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Tropical Medicine & International Health. 9(9). 967–974. 25 indexed citations

10.

Clark, Robert L., Tacey White, Sally Clode, et al.. (2004). Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Research Part B Developmental and Reproductive Toxicology. 71(6). 380–394. 110 indexed citations

11.

Falsini, Benedetto, Peter Winstanley, E.K. Mberu, et al.. (2003). The Effect of Quinine on the Electroretinograms of Children with Pediatric Cerebral Malaria. The Journal of Infectious Diseases. 187(8). 1342–1345. 8 indexed citations

12.

Winstanley, Peter, Stephen A. Ward, & Robert W. Snow. (2002). Clinical status and implications of antimalarial drug resistance. Microbes and Infection. 4(2). 157–164. 78 indexed citations

13.

Winstanley, Peter. (2001). Chlorproguanil‐dapsone (LAPDAP) for uncomplicated falciparum malaria. Tropical Medicine & International Health. 6(11). 952–954. 40 indexed citations

14.

Sibley, Carol Hopkins, John E. Hyde, Paul F. G. Sims, et al.. (2001). Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?. Trends in Parasitology. 17(12). 582–588. 292 indexed citations

15.

Sibley, Carol Hopkins, John E. Hyde, Paul F. G. Sims, et al.. (2001). Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?. Trends in Parasitology. 17(12). 570–571. 25 indexed citations

16.

Winstanley, Peter. (2001). Modern chemotherapeutic options for malaria. The Lancet Infectious Diseases. 1(4). 242–250. 52 indexed citations

17.

Winstanley, Peter & Alasdair Breckenridge. (1997). Therapeutics and drug development. The Lancet. 349. S3–S4. 3 indexed citations

18.

Winstanley, Peter. (1997). New prospects for the treatment of malaria. Expert Opinion on Investigational Drugs. 6(4). 447–451. 1 indexed citations

19.

Winstanley, Peter, et al.. (1997). Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range. Transactions of the Royal Society of Tropical Medicine and Hygiene. 91(3). 322–327. 55 indexed citations

20.

Edwards, Geoffrey, Peter Winstanley, & Stephen A. Ward. (1994). Clinical Pharmacokinetics in the Treatment of Tropical Diseases. Clinical Pharmacokinetics. 27(2). 150–165. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact